FindTrial
Sign In

Expressions of vaginal phosphodiesterase 5 and nitric oxide synthase in women with female sexual dysfunction

Expressions of vaginal phosphodiesterase 5 and nitric oxide synthase in women with female sexual dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000309
Enrollment
40
Registered
2012-01-04
Start date
2012-01-09
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Bucheon St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Non-menopausal women age 40 or older 2) women who had over 2 times regular sexual intercourse past 6 months 3) women agreed to undergo excision of vaginal tissue and answered female sexual function index questionnaire

Exclusion criteria

Exclusion criteria: 1) menopausal women 2) women had undergone hysterectomy, oophorectomy or vaginal surgery 3) women undergone estrogen therapy 4) cystocele, more than grade 2 5) DM 6) depression, antipsychotic drug users, and other disease which impact on sexual function

Design outcomes

Primary

MeasureTime frame
intensity of PDE5 and eNOS on immunochemical stain;intensity of PDE5 and eNOS on Western blot—

Countries

Korea, Republic of

Contacts

Public ContactKang Jun Cho

The Catholic University of Korea, Bucheon St. Mary's Hospital

chokangjun@gmail.com+82-32-340-2267

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026